China · 
What does Lyfe Capital invest in?
Lyfe Capital invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Healthcare.
Lyfe Capital highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Series C: 100% of its rounds
What they do
A premier healthcare investment platform that connects healthcare champions with global markets, supply chains, and strategic partners.From their own website
- Type
- Growth equity
- Cheque size
- Not stated
- Stages
- Series ASeries BGrowth
- Sectors
- Healthcare
- Based in
- Singapore, China
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first3 appearances
- 2026
1 round
- Oct
- 2023
1 round
- Apr
- 2019
1 round
- Aug
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
GCGang ChenDirectoriFiling they signed
HLHo Li YaoMemberiFiling they signed
JZJin ZhaoShareholder/DirectoriForm ADV
LHLi Ho YaoMemberiForm ADV
ZYZhengkun YuDirectoriFiling they signed
We also hold 28 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$2.3Bgross assets of its funds, 4 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- LYFE Capital Global Partner Limited
- SEC number
- CRD 319141
What they claim to have backed
From their own portfolio page (on their website)
0 of 1 we have independently watched raise
Level Up Digital
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.